Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cardiac patient management at Guidant

This article was originally published in The Gray Sheet

Executive Summary

FDA approval of the Contak Renewal 3 RF cardiac resynchronization therapy defibrillator and Zoom Latitude programmer will allow physicians to use remote monitoring to evaluate patients at three times the interrogation speed of the firm's previous programmer. Guidant plans to introduce the technology in the U.S. in Q4. Medtronic markets the CardioSight data access tool to cardiologists whose patients have been implanted with a defibrillator such as the InSync Sentry (1"The Gray Sheet" Aug. 22, 2005, In Brief)...

Related Content

Latitude for Guidant
Cardiac monitoring for cardiologists



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts